fig3

Figure 3. ^*If ongoing studies confirm the equivalence or superiority of biomarkers (i.e., GALAD) over US, they could replace US in surveillance. Risk calculators of hepatocellular carcinoma and proposal for risk-stratified surveillance. Pertinent references are provided in the Supplementary Materials. ALD: Alcoholic liver disease; HBV: hepatitis B virus; HCV: hepatitis C virus; HCC: hepatocellular carcinoma; MAFLD: metabolic-associated steatotic liver disease; GALAD: gender, age, lectin-bound AFP, AFP, des-carboxy prothrombin.